EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gut-microbiota-derived indole sulfate promotes heart failure in chronic kidney disease

Yun Zhang, Xuejie Han, Tao Feng, Zewen Li, Hui Yu, Ye Chen, Yunlong Gao, Qianhui Gao, Linwei Zhang, Shanshan Li, Ling Shi, Xiru Zhang und 3 weitere

Cell Host & Microbe · 2025-10 · 33 (10) · 1715-1730.e5

DOI: 10.1016/j.chom.2025.08.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Host & Microbe, 2025-10. Verfasst von Yun Zhang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Microbiome Medicine Center, Department of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou 510000, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Renal Insufficiency, Chronic, Heart Failure, Indican. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heart failure (HF) is highly prevalent in chronic kidney disease (CKD) and associates with alterations in gut microbiota, although the underlying mechanisms remain unclear, complicating diagnosis and treatment. In this study, we identify indoxyl sulfate (IS), produced by E. coli through the tryptophanase (TnaA) pathway, as a key metabolite involved in CKD-related HF. Mechanistically, IS disrupts cardiac mitochondrial function and induces myocardial apoptosis via the AHR-CYP1B1 axis, driving HF progression. To target this gut-microbiota-IS axis for clinical improvement of CKD-related HF, we applied probiotics to reduce E. coli abundance and IS levels, resulting in improved cardiac outcomes in rats and CKD patients. This study was registered at the Chinese Clinical Trial Register (https://www.chictr.org.cn: ChiCTR2500098366 and ChiCTR2500100588). Furthermore, E. coli abundance shows diagnostic potential for early prediction of HF onset within 6 months in a prospective CKD cohort study. These findings underscore the critical role of gut microbiota in CKD-related HF and suggest a microbiota-targeted therapeutic and diagnostic strategy for clinical intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeRenal Insufficiency, ChronicHeart FailureIndicanAnimalsHumansRatsEscherichia coliMaleProbioticsFemaleMiddle AgedRats, Sprague-DawleyAgedTryptophanaseApoptosis

Stichwörter der Autor:innen

Escherichia colichronic kidney diseaseheart failureindoxyl sulfate

Substanzen

IndicanTryptophanase

Autor:innen und Institutionen

  • Microbiome Medicine Center, Department of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou 510000, China.
  • Department of Cardiology, the First Affiliated Hospital, Harbin Medical University, Harbin 150001, China.
  • Department of Gastroenterology, Integrative Microecology Clinical Center, Shenzhen Key Laboratory of Gastrointestinal Microbiota and Disease, Shenzhen Clinical Research Center for Digestive Disease, Shenzhen Hospital, S…
  • Microbiome Medicine Center, Department of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou 510000, China. Electronic address: jiandandjx@smu.edu.cn.
  • Department of Cardiology, the First Affiliated Hospital, Harbin Medical University, Harbin 150001, China. Electronic address: ly99ly@vip.163.com.
  • Microbiome Medicine Center, Department of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou 510000, China; Department of Cardiology, Shenzhen Hospital, Southern Medical University, Shenzhen…

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • China Postdoctoral Science Foundation
  • Key Technologies Research and Development Program of Guangzhou Municipality
  • Natural Science Foundation of Guangzhou Municipality

Zitieren

APA

Zhang, Y., Han, X., Feng, T., Li, Z., Yu, H., Chen, Y., Gao, Y., Gao, Q., Zhang, L., Li, S., Shi, L., Zhang, X., Li, Z., Li, Y., & Zhou, H. (2025). Gut-microbiota-derived indole sulfate promotes heart failure in chronic kidney disease. Cell Host & Microbe, 33(10), 1715-1730.e5. https://doi.org/10.1016/j.chom.2025.08.014

Vancouver

Zhang Y, Han X, Feng T, Li Z, Yu H, Chen Y, et al. Gut-microbiota-derived indole sulfate promotes heart failure in chronic kidney disease. Cell Host & Microbe. 2025;33(10):1715-1730.e5. doi:10.1016/j.chom.2025.08.014

BibTeX
@article{Zhang2025,
  author = {Zhang, Yun and Han, Xuejie and Feng, Tao and Li, Zewen and Yu, Hui and Chen, Ye and Gao, Yunlong and Gao, Qianhui and Zhang, Linwei and Li, Shanshan and Shi, Ling and Zhang, Xiru and Li, Zhuang and Li, Yue and Zhou, Hongwei},
  title = {Gut-microbiota-derived indole sulfate promotes heart failure in chronic kidney disease},
  journal = {Cell Host & Microbe},
  year = {2025},
  volume = {33},
  number = {10},
  pages = {1715--1730.e5},
  doi = {10.1016/j.chom.2025.08.014}
}
Kostenlos starten →